Check out the latest article in my newsletter: Where Controlled Fire Meets Wandering Light: The Trials and Observational Studies Duet. https://t.co/NG4iLgGQ5L via @LinkedIn
Data-driven action is key to stopping Lassa fever before it spreads & building stronger epidemic preparedness.
Dr @MEyambe will speak at #ECOWASLIC2025, sharing insights that turn research into solutions.
Register today to join us: https://t.co/Ob9Nm1puEU
Have your say on CRA fee practices in Africa! 🌍
We're gathering insights from CRAs, sponsors, CROs, regulators & sites to build fair, transparent fee models. Just 3 min to help strengthen Africa’s clinical research ecosystem. 💡
👉 Take the survey:
https://t.co/LjDM0vDFVZ
Big news for science and public health with the first Ph2 trial of a Lassa vaccine candidate.
Personally proud to see this start in Nigeria, & look forward to the expansion to other countries.
One step closer, the journey continues.
@IfedayoTiffy Not just for Monkeypox, I think we should continue with Lassa fever, Ebola, Crimean Congo, Rift Valley fever, etc. There is urgent need of a better naming system moving forward.
Pancreatic cancer is one of the deadliest cancers, with few treatment options.
Now, a new vaccine, developed by scientists in New York with the team behind the @pfizer/ @BioNTech_Group COVID-19 vaccine has shown promise in the clinic.
@Telegraph 👇
https://t.co/uLIGjD7q4e
Did you know❓Our study, Enable, is the largest ever research programme to provide a more accurate assessment of Lassa fever infections in West Africa.
The study is running across Benin 🇧🇯, Liberia 🇱🇷, Guinea 🇬🇳, Nigeria 🇳🇬 and Sierra Leone 🇸🇱: https://t.co/I61gtRdFEj